Art

J-GLOBAL ID：201602227118929105   Reference number：16A1068568

Protection from lethal herpes simplex virus type 1 infection by vaccination with a UL41-deficient recombinant strain

UL41欠失組換え系統のワクチン接種による致死性の単純ヘルペスウイルス1型感染の予防

Author (5)： Koshizuka Tetsuo (Department of Microbiology, Fukushima Medical University School of Medicine) ,  Ishioka Ken (Department of Microbiology, Fukushima Medical University School of Medicine) ,  Kobayashi Takahiro (Department of Microbiology, Fukushima Medical University School of Medicine) ,  Ikuta Kazufumi (Department of Microbiology, Fukushima Medical University School of Medicine) ,  Suzutani Tatsuo (Department of Microbiology, Fukushima Medical University School of Medicine)
Material： Fukushima Journal of Medical Science (Web)  (Fukushima J Med Sci (Web))
Volume： 62  Issue： 1  Page： 36-42(J-STAGE)  Publication year： 2016 
JST Material Number： U0218A  ISSN： 2185-4610  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： model ,...
Semi thesaurus term： mouse model ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1068568&from=J-GLOBAL&jstjournalNo=U0218A") }}

Author keywords (3)： vaccine ,  UL41 gene ,  herpes simplex virus

JST classification (1)： Basic research of immunotherapeutic agents and blood preparations  (GW22010D)

Reference (34)：

• 1. Stanberry LR, Cunningham AL, Mindel A, et al. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis, 30: 549-566, 2000.
• 2. Mindel A, Faherty A, Carney O, Patou G, Freris M, Williams P. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet, 1: 926-928, 1988.
• 3. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med, 124: 8-15, 1996.
• 4. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med, 337: 1105-1111, 1997.
• 5. Straus SE, Corey L, Burke RL, et al. Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet, 343: 1460-1463, 1994.

Terms in the title (7)： 欠失 ,  組換え ,  系統 ,  ワクチン接種 ,  単純ヘルペスウイルス1型 ,  感染 ,  予防